PIOGLITAZON Mepha Teva cpr 30 mg 28 pce
7680620950157
CH-62095
A10BG03
07.06.2.
Reimbursement limitations:
ACTOS2
A utiliser lorsque d'autres antidiabétiques oraux sont contre-indiqués ou non appropriés pour des raisons médicales …
1 / 3
google
Details
- Product number
- 6209502
- CPT
- -
- Packaging group
- 28
- Unit
- Tablette(n)
- Composition
- pioglitazonum 30 mg ut pioglitazoni hydrochloridum, lactosum monohydricum 75.54 mg, carmellosum calcicum, hydroxypropylcellulosum, magnesii stearas, pro compresso.
Articles (1)
Pioglitazon-Mepha Teva 30 mg, Tabletten
Tabletten
28
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
75.54 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 42.40
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/06/2021
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 62095
- Drug name
- Pioglitazon-Mepha Teva, Tabletten
- Galenic form
- TAB
- ATC Code
- A10BG03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 07/11/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 07.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PIOGLITAZON Mepha Teva cpr 30 mg 28 pce
- Description (DE)
- PIOGLITAZON Mepha Teva Tabl 30 mg 28 Stk
- Market launch
- 07/11/2011
- Narcotic (BTM)
- No